福州爱尔眼科医院有限公司

爱尔眼科医院集团是知名全球连锁眼科医疗机构，IPO上市医疗机构（股票代码: 300015，2015年入选沪深300指数股）。截至2019年，已在中国大陆30个省市区建立290余家专业眼科医院，覆盖全国医保人口超过70%，年门诊量超过650 万人。并且，在美国、欧洲和中国香港开设有80余家眼科医院。

Aier eye hospital group is a well-known global chain of eye hospitals, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of 2019, Aier Eye Hospital Group has established more than 290 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 6.5 million outpatient visits annually. Recently, There are more than 80 ophthalmic branches in the United States, Europe and Hongkong.

爱尔眼科致力于引进和吸收国际同步的眼科技术与医疗管理理念，以专业化、规模化、科学化为发展战略，推动中国眼科医疗事业的发展。

Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.

通过不断的探索与实践，并充分吸纳国际先进的医疗管理经验的基础上，成功探索出一套适应中国国情和市场环境的眼科医院连锁经营管理模式——“分级连锁”。利用人才、技术和管理等方面的优势，通过全国各连锁医院良好的诊疗质量、优质的医疗服务和专业的市场推广，使爱尔眼科成为全国各地眼科患者信赖的眼科医院。

Base on constant exploration and practice, also with absorb advanced international medical management experience, Aier Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country.

2013年，爱尔眼科医院集团与中南大学联合成立专业的眼科医学院——中南大学爱尔眼科学院，主要培养眼科硕、博士高级医疗人才；2014年，再度与湖北科技大学联合成立爱尔眼视光学院。2011年和2015年，爱尔眼科先后成立“爱尔眼视光研究所”和“爱尔眼科研究所”。至此，爱尔眼科打通了眼科的医、学、研三大领域，学院和研究所的成立将使爱尔眼科的科研及临床水平得到显着提升，并以此推动中国眼科医疗事业的发展和进步。

In 2013, Aier and Central South University jointly set up Aier School of ophthalmology, CSU, to educate and train medical professionals with advanced degrees; Once again in 2014, Aier joined the Hubei University of Science and Technology to establish the Aier School of Ophthalmology & Optometry. In 2011 and 2015, Aier established the Aier Institute of Optometry and Aier Institute of Ophthalmology respectively. At this point, Aier has bridged all three areas of medicine, education and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.

截止2016年，爱尔眼科所属的专业眼科专家和医生团队达到近3000名，包括一大批硕士生导师、博士生导师、博士、博士后、留学欧美的学者以及临床经验丰富的核心专家，是中国眼科领域备受瞩目的有生力量。

As of 2016, Aier has recruited and trained over 3000 doctors and specialized experts, many of whom have studied in elite institutions in Europe and the US. They are China’s driving force in ophthalmology.

2014年7月9日，世界银行行长金墉参观考察爱尔眼科长沙医院，并在全球发展中国家推广爱尔眼科独具特色的可持续公益慈善模式。2015年，爱尔眼科收购香港亚洲医疗集团，开启爱尔眼科国际化步伐，2017年，爱尔眼科收购美国知名眼科中心，国际化步伐再下一城。

On July 9,2014, the President of the World Bank Jim Yong Kim visited Changsha Aier Eye Hospital and promoted Aier’s unique sustainable philanthropic model in developing countries. In 2015, Aier acquired Hong Kong Asia Medical Group and paved the way for Aier’s internationalization. In early 2017, Aier acquired a renowned eyecare center in American, which brought Aier’s international expansion to a new stage.

爱尔眼科的发展壮大，始终以“使所有人，无论贫穷富裕，都享有眼健康的权利”为使命，追求社会责任和自身发展的和谐统一，通过开创性的“交叉补贴”模式，一方面为患者提供更高品质的眼科医疗服务，同时全面开展防盲治盲工作、投身社会公益和帮助弱势群体，并联合社会各界，推动整个中盲事业的全面发展。

Since its founding, Aier always committed to the mission, “Everyone in everywhere, we do care “. With its "cross subsidy" model, Aier provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness.

随着中国医疗卫生体制改革的进一步推进，爱尔眼科顺应国家医疗卫生政策和发展趋势，于2014年在医疗行业推出“合伙人计划”，致力于改变眼科医生执业的生态环境，***限度地激发核心骨干的创造力和能动性。爱尔眼科专注于眼科医疗服务事业，预计到 2020年，兴建1000家具有竞争力的专业连锁眼科医院，为更多的人提供高质量、多层次的眼科医疗服务。

In 2014, Aier launched the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members. It is expected that by the end of 2020, Aier will have 1000 eye hospitals which provide high quality and multi-level eye care to more people.